Organovo Holdings Inc (NYSE MKT LLC:ONVO)

4.56
Delayed Data
As of Apr 17
 -0.16 / -3.39%
Today’s Change
3.29
Today|||52-Week Range
9.25
-37.10%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$366.9M

Company Description

Organovo Holdings, Inc. is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo Holdings was founded on January 30, 2012 and is headquartered in San Diego, CA.

Contact Information

Organovo Holdings, Inc.
6275 Nancy Ridge Drive
San Diego California 92121
P:(858) 224-1000
Investor Relations:
(858) 224-1003

Employees

Shareholders

Individual stakeholders20.61%
Mutual fund holders13.92%
Other institutional11.02%

Top Executives

Keith MurphyChairman, President & Chief Executive Officer
Barry D. MichaelsCFO, Secretary & Head-Investor Relations
Sharon Collins PresnellCTO, Executive VP-Research & Development
Eric Michael DavidChief Strategy Officer
Michael RenardEVP-Commercial Operations & Head-Media Relations

To view my watchlist

Not a member yet?

Sign up now for a free account